Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
W Hassen
(1, 2)
,
A Kassambara
(1, 3)
,
T Reme
(1, 3)
,
S Sahota
(4)
,
A Seckinger
(5, 6)
,
L Vincent
(7)
,
G Cartron
(7)
,
J Moreaux
(1, 3, 8)
,
D Hose
(5, 6)
,
B Klein
(1, 3, 8)
1
IGH -
Institut de génétique humaine
2 ISBM - Institut Supérieur de Biotechnologie de Monastir
3 CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Haematology, Montpellier, France
4 University of Southampton
5 Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany
6 Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany
7 CHU Montpellier, Department of Clinical Hematology, Montpellier, France
8 UM1 - Université Montpellier 1
2 ISBM - Institut Supérieur de Biotechnologie de Monastir
3 CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Haematology, Montpellier, France
4 University of Southampton
5 Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany
6 Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany
7 CHU Montpellier, Department of Clinical Hematology, Montpellier, France
8 UM1 - Université Montpellier 1